health doc connect care telemedicine 100787926 large

Mumbai-based healthtech startup (formerly known as Tatva Health) on Thursday announced that it has raised an undisclosed amount of seed funding led by Kae Capital and Whiteboard Capital. Angels Puneet Kumar from Steadview Capital and Suhail Sameer from BharatPe also participated in the round.

Traya was founded by Saloni Anand, a techie-turned-marketeer, and Altaf Saiyed, a Stanford Business School alumnus. It helps millennials get doctor prescribed and customised hair loss solutions at the tap of a finger. The startup has developed a combination of three sciences — Ayurveda, allopathy, and nutrition — to create a comprehensive treatment plan for hair loss conditions.

Saloni Anand, Co-founder, Traya said, “It’s unfortunate how most people accept hair loss and balding as an inevitability. We want to make sure that people know that hair loss is manageable. Especially if treated in a timely manner, we are not a product company selling yet another shampoo, we work with our customers closely to get their hair health sorted for long-term effective results.”

Gaurav Chaturvedi, Partner at Kae Capital, said “Traya’s offering of doctor-backed, personalised products based on a combination of sciences along with tech-enabled customer service is the right way to solve the hair loss problem.”

“As investors across various D2C and healthcare companies, we find Traya a very exciting company deep-rooted in medicine and at the same time, contemporary and consumer-centric in solving real and serious healthcare problems starting with a large category like hair fall,” added Anshu Prasher, General Partner at Whiteboard Capital.

It plans to focus on hair loss this year and then venture to other lifestyle problems that millennials grapple with. The startup believes its approach of mixing science with an infrastructure of adherence can help the youth manage health problems they otherwise cannot.

This round of funds will be used by the Mumbai-based startup for research and development, expanding the product range, detailed clinical trials and creating a strong and comprehensive adherence programme using cutting edge technology.


Comment your thoughts

Your email address will not be published. Required fields are marked *